首页 > 最新文献

Revista de la Facultad de Ciencias Medicas de Cordoba最新文献

英文 中文
[Anemia and heart failure with preserved ejection fraction in adult patients with cardiorenal syndrome: a cross-sectional study] [成人心肾综合征患者保留射血分数的贫血和心力衰竭:一项横断面研究]
Q3 Medicine Pub Date : 2025-03-31 DOI: 10.31053/1853.0605.v82.n1.44359
Maria Teresa Politi, Gustavo Javier Daquarti, Damián Néstor Spagnuolo, Raúl Ferreyra, Mirta Diez, Guillermo Bortman

Introduction: Patients hospitalized for heart failure with preserved ejection fraction (HFpEF) have a higher prevalence of anemia than those hospitalized for heart failure with reduced ejection fraction (HFpEF). However, it is unknown if this relationship is maintained in patients with chronic kidney disease, forming cardiorenal syndrome type IV.

Methods: Cross-sectional, multicenter study of patients with chronic kidney disease hospitalized for heart failure. The primary outcome was the difference in hemoglobin concentration. The secondary outcome was the difference in the prevalence of anemia.

Results: 229 patients were enrolled. Hemoglobin concentration was lower in patients with HFpEF compared to patients with HFrEF (11.1±1.8 g/dl vs 12.3±2.0 g/dl; p < 0.0001). . Presenting HFpEF was associated with a lower hemoglobin concentration (β1 = -0.90 g/dl; p = 0.001), after including the use of iron supplements, moderate to severe deterioration of glomerular filtration rate, sex and age. The prevalence of anemia was higher in patients with HFpEF compared to those with HFrEF (72.3% vs 59.8%; p = 0.0462). Belonging to the HFpEF group was not associated with anemia (OR = 1.77; p = 0.078), after including the same covariates. Exploratory, belonging to the HFpEF group was associated with moderate to severe anemia, after including the same covariates.

Conclusion: In patients with type IV cardiorenal syndrome, hemoglobin concentration is lower in patients hospitalized with HFpEF, possibly playing a role in the destabilization of these patients.

导论:因射血分数保留(HFpEF)心力衰竭住院的患者比因射血分数降低(HFpEF)心力衰竭住院的患者有更高的贫血患病率。然而,这种关系在慢性肾脏疾病患者中是否维持,形成心肾综合征iv型尚不清楚。方法:对因心力衰竭住院的慢性肾脏疾病患者进行横断面、多中心研究。主要结果是血红蛋白浓度的差异。次要结果是贫血患病率的差异。结果:229例患者入组。HFpEF患者的血红蛋白浓度低于HFrEF患者(11.1±1.8 g/dl vs 12.3±2.0 g/dl);P < 0.0001)。出现HFpEF与较低的血红蛋白浓度相关(β1 = -0.90 g/dl;P = 0.001),包括使用铁补充剂后,中度至重度肾小球滤过率恶化,性别和年龄。HFpEF患者的贫血患病率高于HFrEF患者(72.3% vs 59.8%;P = 0.0462)。属于HFpEF组与贫血无关(OR = 1.77;P = 0.078),包括相同的协变量后。探索性的,在纳入相同的协变量后,属于HFpEF组与中度至重度贫血相关。结论:在IV型心肾综合征患者中,HFpEF住院患者的血红蛋白浓度较低,可能在这些患者的不稳定中起作用。
{"title":"[Anemia and heart failure with preserved ejection fraction in adult patients with cardiorenal syndrome: a cross-sectional study]","authors":"Maria Teresa Politi, Gustavo Javier Daquarti, Damián Néstor Spagnuolo, Raúl Ferreyra, Mirta Diez, Guillermo Bortman","doi":"10.31053/1853.0605.v82.n1.44359","DOIUrl":"10.31053/1853.0605.v82.n1.44359","url":null,"abstract":"<p><strong>Introduction: </strong>Patients hospitalized for heart failure with preserved ejection fraction (HFpEF) have a higher prevalence of anemia than those hospitalized for heart failure with reduced ejection fraction (HFpEF). However, it is unknown if this relationship is maintained in patients with chronic kidney disease, forming cardiorenal syndrome type IV.</p><p><strong>Methods: </strong>Cross-sectional, multicenter study of patients with chronic kidney disease hospitalized for heart failure. The primary outcome was the difference in hemoglobin concentration. The secondary outcome was the difference in the prevalence of anemia.</p><p><strong>Results: </strong>229 patients were enrolled. Hemoglobin concentration was lower in patients with HFpEF compared to patients with HFrEF (11.1±1.8 g/dl vs 12.3±2.0 g/dl; p < 0.0001). . Presenting HFpEF was associated with a lower hemoglobin concentration (β1 = -0.90 g/dl; p = 0.001), after including the use of iron supplements, moderate to severe deterioration of glomerular filtration rate, sex and age. The prevalence of anemia was higher in patients with HFpEF compared to those with HFrEF (72.3% vs 59.8%; p = 0.0462). Belonging to the HFpEF group was not associated with anemia (OR = 1.77; p = 0.078), after including the same covariates. Exploratory, belonging to the HFpEF group was associated with moderate to severe anemia, after including the same covariates.</p><p><strong>Conclusion: </strong>In patients with type IV cardiorenal syndrome, hemoglobin concentration is lower in patients hospitalized with HFpEF, possibly playing a role in the destabilization of these patients.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"22-40"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057712/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Dermatofibrosarcoma protuberans treated with Mohs surgery] 【莫氏手术治疗隆突性皮肤纤维肉瘤】
Q3 Medicine Pub Date : 2025-03-31 DOI: 10.31053/1853.0605.v82.n1.45363
Lía Salomé Abeledo, Carla Barbini, Gerardo Russier, Corina Busso

Objetives: Dermatofibrosarcoma protuberans is a sarcomatous neoplasm with low incidence. It exhibits slow growth; however, it has the capacity to involve deep tissues. Clinically, it can mimic benign lesions, presenting as thickened or atrophic plaques that slowly transform into protruding lesions. The treatment of choice is surgical excision, with Mohs micrographic surgery standing out for its advantages.

Clinical case: A 40-year-old male patient with dermatofibrosarcoma protuberans on the back underwent excision using the Mohs technique, with no tumor recurrence after two years of follow-up. Conclusion: It is important to highlight that the Mohs technique offers advantages over conventional methods, allowing for tissue optimization, ensuring clear margins, and achieving a low recurrence rate

Conclusion: It is important to highlight that the Mohs technique offers advantages over conventional methods, allowing for tissue optimization, ensuring clear margins, and achieving a low recurrence rate

目的:隆突性皮肤纤维肉瘤是一种低发病率的肉瘤性肿瘤。它生长缓慢;然而,它有能力涉及深层组织。临床上,它可以模拟良性病变,表现为增厚或萎缩斑块,慢慢转变为突出的病变。治疗的选择是手术切除,莫氏显微手术以其优势而突出。临床病例:男性,40岁,背部皮肤纤维肉瘤隆突,采用Mohs技术切除,随访2年无复发。结论:Mohs技术与传统方法相比,具有组织优化、边缘清晰、复发率低的优势。结论:Mohs技术与传统方法相比,具有组织优化、边缘清晰、复发率低的优势
{"title":"[Dermatofibrosarcoma protuberans treated with Mohs surgery]","authors":"Lía Salomé Abeledo, Carla Barbini, Gerardo Russier, Corina Busso","doi":"10.31053/1853.0605.v82.n1.45363","DOIUrl":"10.31053/1853.0605.v82.n1.45363","url":null,"abstract":"<p><strong>Objetives: </strong>Dermatofibrosarcoma protuberans is a sarcomatous neoplasm with low incidence. It exhibits slow growth; however, it has the capacity to involve deep tissues. Clinically, it can mimic benign lesions, presenting as thickened or atrophic plaques that slowly transform into protruding lesions. The treatment of choice is surgical excision, with Mohs micrographic surgery standing out for its advantages.</p><p><strong>Clinical case: </strong>A 40-year-old male patient with dermatofibrosarcoma protuberans on the back underwent excision using the Mohs technique, with no tumor recurrence after two years of follow-up. Conclusion: It is important to highlight that the Mohs technique offers advantages over conventional methods, allowing for tissue optimization, ensuring clear margins, and achieving a low recurrence rate</p><p><strong>Conclusion: </strong>It is important to highlight that the Mohs technique offers advantages over conventional methods, allowing for tissue optimization, ensuring clear margins, and achieving a low recurrence rate</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"165-175"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057716/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ophthalmoplegia as a Rare Initial Presentation of Cryptococcal Meningitis: A Case Report and Literature Review 双核间眼移植物作为隐球菌性脑膜炎的罕见初始表现。
Q3 Medicine Pub Date : 2025-03-31 DOI: 10.31053/1853.0605.v82.n1.44952
Raymundo Solís-Gómez, Itzel A Hernández-Dehesa, Aztlani Adan-Ruiz, Adrián F Sánchez-Cruz, Eduardo Argüelles-González

Introduction: Cryptococcal meningitis (CM) frequently associates immunocompromised patients, specifically in HIV infection, and it has high mortality. Neuro-ophthalmic manifestations are rare in patients with CM, especially internuclear ophthalmoplegia (INO) or wall-eyed bilateral internuclear ophthalmoplegia (WEBINO), most of them the result of secondary vasculitis.

Case report: A 53-year-old woman with chronic hepatic failure, had sudden drowsiness, diplopia, fever, and internuclear ophthalmoplegia. MRI showed generalized leptomeningeal enhancement plus infratentorial nodular enhancement type in the midbrain and left cerebellar hemisphere. An India ink test was positive for Cryptococcus neoformans.

Conclusion: Cryptococcal meningitis causes a wide spectrum of neurological manifestations, but neuro-ophthalmological signs are infrequent. Physicians should consider that these meningitis events are capable of generating symptoms due to intra-axial involvement of the Central Nervous System (CNS) due to vasculitis.

介绍。隐球菌性脑膜炎(MC)通常与免疫受损的患者,特别是艾滋病毒感染患者的高死亡率有关。神经眼睑的表现在CM患者中很少见,特别是核间眼睑增生(INO)或双核间眼睑增生(WEBINO),大多数是继发性血管炎的结果。案例报告。53岁女性,慢性肝功能衰竭,出现突然嗜睡、远视、发烧和核间眼部移位。核磁共振显示全局性细脑膜增强加上中脑和左脑半球的腹下结节增强。中国墨水检测呈新形隐球菌阳性。结论。隐球菌性脑膜炎引起广泛的神经表现,但神经眼部体征很少见。医生应考虑到这些脑膜炎事件可能导致血管炎对中枢神经系统(CNS)轴间损伤的症状。
{"title":"Ophthalmoplegia as a Rare Initial Presentation of Cryptococcal Meningitis: A Case Report and Literature Review","authors":"Raymundo Solís-Gómez, Itzel A Hernández-Dehesa, Aztlani Adan-Ruiz, Adrián F Sánchez-Cruz, Eduardo Argüelles-González","doi":"10.31053/1853.0605.v82.n1.44952","DOIUrl":"10.31053/1853.0605.v82.n1.44952","url":null,"abstract":"<p><strong>Introduction: </strong>Cryptococcal meningitis (CM) frequently associates immunocompromised patients, specifically in HIV infection, and it has high mortality. Neuro-ophthalmic manifestations are rare in patients with CM, especially internuclear ophthalmoplegia (INO) or wall-eyed bilateral internuclear ophthalmoplegia (WEBINO), most of them the result of secondary vasculitis.</p><p><strong>Case report: </strong>A 53-year-old woman with chronic hepatic failure, had sudden drowsiness, diplopia, fever, and internuclear ophthalmoplegia. MRI showed generalized leptomeningeal enhancement plus infratentorial nodular enhancement type in the midbrain and left cerebellar hemisphere. An India ink test was positive for Cryptococcus neoformans.</p><p><strong>Conclusion: </strong>Cryptococcal meningitis causes a wide spectrum of neurological manifestations, but neuro-ophthalmological signs are infrequent. Physicians should consider that these meningitis events are capable of generating symptoms due to intra-axial involvement of the Central Nervous System (CNS) due to vasculitis.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"176-187"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057709/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Residual hypoxemia during titration with self-adjusting CPAP at home in patients without prior adaptation] [未适应的患者在家中自行调节CPAP滴定时残留低氧血症]
Q3 Medicine Pub Date : 2025-03-31 DOI: 10.31053/1853.0605.v82.n1.44671
Julieta Franzoy, Magali Blanco, Glenda Ernst, Maria Belen Ginetti, Marcella Perri, Eduardo Borsini

Introduction: Self-adjusting titration (APAP) at home is accepted to define therapeutic pressure (CPAPT). The APAP device report may be insufficient to ensure adequate therapeutic response in all patients. There is no consensus on the use of oximetry during APAP titration.

Objective: To evaluate the prevalence and magnitude of residual hypoxemia (RH) in titration with APAP not monitored at home and to identify related variables.

Materials and methods: Retrospective study based on APAP titrations with coupled oximetry, arterial blood gases and spirometry test. A T90 > 10% of the night was considered significant RH. Predictors of HR were identified by logistic regression (RL).

Results: 116 cases were included. 41% in the group with RH. These were older (66.7 vs. 59.6 years, p: 0.02), lower absolute FEV1 (2.17 vs. 2.57 liters, p: 0.06), lower absolute FVC (2.9 vs. 3.3 liters, p: 0.02) and lower basal PO2 (77.3 vs. 84.2 mmHg, p: 0.04). The titration period reached 3.6 ± 1 nights, average adherence of 374 ± 88.4 minutes/night; CPAPT (cm H2O): 9.4 ± 1.8, AHIr; 3.1 ± 3.2 ev/h and leaks (liters/min): 19.7 ± 11.2. Multiple logistic regression identified age > 66 years as a predictor of RH (OR 3.32, 95% CI 1.43 - 7.69, p: 0.005) and FEV1 < 1.76 liters (OR 3.29 – IC95% 1.27 – 8.53, p: 0.0139).

Conclusions: Incompletely corrected nocturnal oximetry was observed in a significant proportion of patients with APAP. Age over 66 years and absolute FEV1 < 1.76 liters were correlated with residual hypoxemia.

自我调节滴定(APAP)在家庭被接受来定义治疗压力(cpap)。APAP装置报告可能不足以确保所有患者都有足够的治疗反应。在APAP滴定过程中,氧饱和度的使用尚无共识。目的:评价未在家监测的APAP滴定中残留低氧血症(RH)的发生率和程度,并确定相关变量。材料与方法:回顾性研究基于APAP滴定与血氧仪、动脉血气和肺活量测定联合试验。A T90 >为夜间被认为是显著的RH的10%。通过logistic回归(RL)确定HR的预测因素。结果:共纳入116例。RH组有41%。这些患者年龄较大(66.7 vs. 59.6岁,p: 0.02),绝对FEV1较低(2.17 vs. 2.57升,p: 0.06),绝对FVC较低(2.9 vs. 3.3升,p: 0.02),基础PO2较低(77.3 vs. 84.2 mmHg, p: 0.04)。滴定周期为3.6±1晚,平均坚持时间为374±88.4分钟/晚;cpap (cm H2O): 9.4±1.8,AHIr;3.1±3.2 ev/h,泄漏量(升/分钟):19.7±11.2。多元logistic回归确定年龄bbb66岁是RH (OR 3.32, 95% CI 1.43 - 7.69, p: 0.005)和FEV1 < 1.76升(OR 3.29 - IC95% 1.27 - 8.53, p: 0.0139)的预测因子。结论:相当比例的APAP患者存在不完全校正的夜间血氧测定。年龄大于66岁,绝对FEV1 < 1.76 l与残余低氧血症相关。
{"title":"[Residual hypoxemia during titration with self-adjusting CPAP at home in patients without prior adaptation]","authors":"Julieta Franzoy, Magali Blanco, Glenda Ernst, Maria Belen Ginetti, Marcella Perri, Eduardo Borsini","doi":"10.31053/1853.0605.v82.n1.44671","DOIUrl":"10.31053/1853.0605.v82.n1.44671","url":null,"abstract":"<p><strong>Introduction: </strong>Self-adjusting titration (APAP) at home is accepted to define therapeutic pressure (CPAPT). The APAP device report may be insufficient to ensure adequate therapeutic response in all patients. There is no consensus on the use of oximetry during APAP titration.</p><p><strong>Objective: </strong>To evaluate the prevalence and magnitude of residual hypoxemia (RH) in titration with APAP not monitored at home and to identify related variables.</p><p><strong>Materials and methods: </strong>Retrospective study based on APAP titrations with coupled oximetry, arterial blood gases and spirometry test. A T90 > 10% of the night was considered significant RH. Predictors of HR were identified by logistic regression (RL).</p><p><strong>Results: </strong>116 cases were included. 41% in the group with RH. These were older (66.7 vs. 59.6 years, p: 0.02), lower absolute FEV1 (2.17 vs. 2.57 liters, p: 0.06), lower absolute FVC (2.9 vs. 3.3 liters, p: 0.02) and lower basal PO2 (77.3 vs. 84.2 mmHg, p: 0.04). The titration period reached 3.6 ± 1 nights, average adherence of 374 ± 88.4 minutes/night; CPAPT (cm H2O): 9.4 ± 1.8, AHIr; 3.1 ± 3.2 ev/h and leaks (liters/min): 19.7 ± 11.2. Multiple logistic regression identified age > 66 years as a predictor of RH (OR 3.32, 95% CI 1.43 - 7.69, p: 0.005) and FEV1 < 1.76 liters (OR 3.29 – IC95% 1.27 – 8.53, p: 0.0139).</p><p><strong>Conclusions: </strong>Incompletely corrected nocturnal oximetry was observed in a significant proportion of patients with APAP. Age over 66 years and absolute FEV1 < 1.76 liters were correlated with residual hypoxemia.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"61-77"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057706/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Hypoglycemia in a patient with pleural solitary fibrous tumor and response to pasireotide] [一例胸膜孤立性纤维性肿瘤患者的低血糖及对pasireotide的反应]
Q3 Medicine Pub Date : 2025-03-31 DOI: 10.31053/1853.0605.v82.n1.44424
Elizabeth Karen Videla, Pablo Ferrada, Jorge Miller, Eduardo Torres, Analía Álvarez, Javier Herrera, Bertha De la Torre

Introduction: hypoglycemia is a common and multifactorial clinical condition. A rare cause is that associated with non-islet cell tumors.

Objective: to report our experience on the management of severe hypoglycemia in a patient with solitary pleural fibrous tumor and his response to pasireotide.

Clinical case: 63-year-old patient with a history of glomerulonephritis, hypothyroidism, arterial hypertension and a one-year diagnosis of solitary pleural fibrous tumor. Referred to endocrinology due to hypoglycemia for 6 months. Acromegaloid features were confirmed. Laboratory: Hct 36%, Hb 11.9 g/dl, GB 3570/mm3 (Eo 2%, Ba2%, Bac 4%, NS 36%, Li 30%, Mo 14% metamyelocytes 1%, myelocytes 11%), platelets 120,000 /mm3, ESR 10 mm, CRP 9 mg/L, TP 114%, TTPK 25 sec, blood glucose 57 mg/dL, renal function, hepatogram and lipid profile without particularities. IGF-1 84 ng/ml (VR 57 - 188), C-peptide 0.10 ng/ml (VR 1.10 - 4.40), somatotropin 0.98 ng/ml (VR up to 2.5) and basal insulin 0.4 uU/ml (VR 2.6 - 24) . IFG-2 measurement is not available in Argentina. A chest CT showed a pleural tumor measuring 13 cm. Without possibilities of surgical resection and without response to chemotherapy. Treatment was started with infusion of 25% dextrose, dexamethasone, pasireotide with good response. The patient died due to an infectious complication.

Conclusion: pasireotide could be a therapeutic alternative in cases that are not candidates for surgery or refractory to other medical treatment.

低血糖是一种常见的多因素临床疾病。一个罕见的原因是与非胰岛细胞肿瘤有关。目的:报告一例单纯性胸膜纤维性肿瘤患者严重低血糖的治疗经验及其对pasireotide的反应。临床病例:63岁,有肾小球肾炎、甲状腺功能减退、动脉高血压病史,诊断为单纯性胸膜纤维性肿瘤一年。因低血糖转诊内分泌科6个月。肢端巨状体特征得到证实。实验室:Hct 36%, Hb 11.9 g/dl, GB 3570/mm3 (Eo 2%, Ba2%, Bac 4%, NS 36%, Li 30%, Mo 14%, metamyelocytes 1%, myelocytes 11%),血小板12万/mm3, ESR 10 mm, CRP 9 mg/L, TP 114%, TTPK 25秒,血糖57 mg/ dl,肾功能、肝图、血脂无特异性。IGF-1 84 ng/ml (VR值57 - 188),c肽0.10 ng/ml (VR值1.10 - 4.40),生长激素0.98 ng/ml (VR值高达2.5),基础胰岛素0.4 uU/ml (VR值2.6 - 24)。阿根廷无法测量IFG-2。胸部CT显示胸膜肿瘤,长13厘米。没有手术切除的可能,对化疗也没有反应。治疗开始时输注25%葡萄糖、地塞米松、帕西肽,疗效良好。病人死于感染并发症。结论:pasireotide可以作为不需要手术或其他药物治疗难治性病例的治疗选择。
{"title":"[Hypoglycemia in a patient with pleural solitary fibrous tumor and response to pasireotide]","authors":"Elizabeth Karen Videla, Pablo Ferrada, Jorge Miller, Eduardo Torres, Analía Álvarez, Javier Herrera, Bertha De la Torre","doi":"10.31053/1853.0605.v82.n1.44424","DOIUrl":"10.31053/1853.0605.v82.n1.44424","url":null,"abstract":"<p><strong>Introduction: </strong>hypoglycemia is a common and multifactorial clinical condition. A rare cause is that associated with non-islet cell tumors.</p><p><strong>Objective: </strong>to report our experience on the management of severe hypoglycemia in a patient with solitary pleural fibrous tumor and his response to pasireotide.</p><p><strong>Clinical case: </strong>63-year-old patient with a history of glomerulonephritis, hypothyroidism, arterial hypertension and a one-year diagnosis of solitary pleural fibrous tumor. Referred to endocrinology due to hypoglycemia for 6 months. Acromegaloid features were confirmed. Laboratory: Hct 36%, Hb 11.9 g/dl, GB 3570/mm3 (Eo 2%, Ba2%, Bac 4%, NS 36%, Li 30%, Mo 14% metamyelocytes 1%, myelocytes 11%), platelets 120,000 /mm3, ESR 10 mm, CRP 9 mg/L, TP 114%, TTPK 25 sec, blood glucose 57 mg/dL, renal function, hepatogram and lipid profile without particularities. IGF-1 84 ng/ml (VR 57 - 188), C-peptide 0.10 ng/ml (VR 1.10 - 4.40), somatotropin 0.98 ng/ml (VR up to 2.5) and basal insulin 0.4 uU/ml (VR 2.6 - 24) . IFG-2 measurement is not available in Argentina. A chest CT showed a pleural tumor measuring 13 cm. Without possibilities of surgical resection and without response to chemotherapy. Treatment was started with infusion of 25% dextrose, dexamethasone, pasireotide with good response. The patient died due to an infectious complication.</p><p><strong>Conclusion: </strong>pasireotide could be a therapeutic alternative in cases that are not candidates for surgery or refractory to other medical treatment.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"127-139"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057705/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143754943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Incidence of acquired morbidity and its impact on patients in a pediatric intensive care unit based on the functional status scale] [基于功能状态量表的儿童重症监护病房患者获得性发病发生率及其影响]
Q3 Medicine Pub Date : 2025-03-31 DOI: 10.31053/1853.0605.v82.n1.45328
Judith Frydman, Mara Inés López

Introduction: a significant number of children suffer cognitive, physical, mental and social limitations as a result of critical illnesses and their subsequent treatment. Pollack et al. developed the functional status scale with the purpose of measuring the change in functional status during hospitalization.

Objectives: evaluate the acquired morbidity upon discharge from the Pediatric Intensive Care Unit (PICU). Specific objectives: compare mortality and acquired morbidity rates, analyze changes in functional status categories, identify the most affected domains, describe relationships between domain affection and admission diagnosis, between domain affection and age group, between morbidity and days in invasive mechanical ventilation (IMV), non-invasive ventilation and high-flow oxygen therapy.

Methodology: observational, descriptive, prospective and longitudinal study. Patients between 1 and 180 months of age requiring ventilatory support for at least 48 hours, between February 2021 and February 2024, were included.

Results: 90.9% survived, and of these, 26.9% developed acquired morbidity. The 42% of patients changed their functional status at least one point. The most affected domains were motor and feeding. Those who died had fewer days of IMV and hospitalization.

Conclusion: The incidence of acquired morbidity was higher than mortality in the analyzed period. Children who developed morbidity remained hospitalized for a longer period of time and had greater requirements and days of IMV. Increased survival makes mortality an insufficient outcome metric. More studies with longer follow-up are needed.

导言:相当数量的儿童由于严重疾病及其随后的治疗而遭受认知、身体、精神和社会方面的限制。Pollack等人开发了功能状态量表,目的是测量住院期间功能状态的变化。目的:评估儿童重症监护病房(PICU)出院后的获得性发病率。具体目标:比较死亡率和获得性发病率,分析功能状态类别的变化,确定最受影响的领域,描述领域情感与入院诊断之间的关系,领域情感与年龄组之间的关系,有创机械通气(IMV),无创通气和高流量氧疗中发病率与天数之间的关系。方法:观察性、描述性、前瞻性和纵向研究。在2021年2月至2024年2月期间,年龄在1至180个月之间需要呼吸支持至少48小时的患者被纳入研究。结果:90.9%的患者存活,其中26.9%发生后发性发病。42%的患者至少改变了一个点的功能状态。受影响最大的领域是运动和进食。死亡患者的IMV和住院天数较短。结论:分析期内获得性发病率高于病死率。发病的儿童住院时间较长,IMV的要求和天数也较大。生存率的提高使死亡率成为不充分的结局指标。需要更多的研究和更长的随访时间。
{"title":"[Incidence of acquired morbidity and its impact on patients in a pediatric intensive care unit based on the functional status scale]","authors":"Judith Frydman, Mara Inés López","doi":"10.31053/1853.0605.v82.n1.45328","DOIUrl":"10.31053/1853.0605.v82.n1.45328","url":null,"abstract":"<p><strong>Introduction: </strong>a significant number of children suffer cognitive, physical, mental and social limitations as a result of critical illnesses and their subsequent treatment. Pollack et al. developed the functional status scale with the purpose of measuring the change in functional status during hospitalization.</p><p><strong>Objectives: </strong>evaluate the acquired morbidity upon discharge from the Pediatric Intensive Care Unit (PICU). Specific objectives: compare mortality and acquired morbidity rates, analyze changes in functional status categories, identify the most affected domains, describe relationships between domain affection and admission diagnosis, between domain affection and age group, between morbidity and days in invasive mechanical ventilation (IMV), non-invasive ventilation and high-flow oxygen therapy.</p><p><strong>Methodology: </strong>observational, descriptive, prospective and longitudinal study. Patients between 1 and 180 months of age requiring ventilatory support for at least 48 hours, between February 2021 and February 2024, were included.</p><p><strong>Results: </strong>90.9% survived, and of these, 26.9% developed acquired morbidity. The 42% of patients changed their functional status at least one point. The most affected domains were motor and feeding. Those who died had fewer days of IMV and hospitalization.</p><p><strong>Conclusion: </strong>The incidence of acquired morbidity was higher than mortality in the analyzed period. Children who developed morbidity remained hospitalized for a longer period of time and had greater requirements and days of IMV. Increased survival makes mortality an insufficient outcome metric. More studies with longer follow-up are needed.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"41-60"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057707/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Advanced maternal age as a risk factor for adverse perinatal outcomes] 母亲年龄大是围产期不良结果的危险因素。
Q3 Medicine Pub Date : 2025-03-31 DOI: 10.31053/1853.0605.v82.n1.45349
Anyhely Yhoan Escudero Quispe, José Luis Vivanco Osorio

This study finds a gradual increase in women's age at first pregnancy, a situation that has been associated with an increased risk of adverse maternal and postpartum events. While in the mid-1970s there were 1.7 per thousand pregnant nulliparous women between 35 and 39 years old, in 2012 this figure increased to 11 per thousand pregnant women, a six-fold increase. The global prevalence of pregnant women over 35 years of age is estimated at 12.3%. Maternal and perinatal characteristics and outcomes of nulliparous women aged 40 years and older are described and compared with characteristics of nulliparous women younger than 40 years. During the time of said study, approximately 4095 nulliparous female patients who met the inclusion criteria were treated; however, a limitation was found because it was a closed population treated in a highly complex tertiary hospital, the majority with high level of schooling and middle class socioeconomic level. In conclusion, older women constitute a high-risk population whose management and follow-up would require a different approach aimed at improving maternal and postpartum outcomes.

这项研究发现,女性在第一次怀孕时的年龄逐渐增加,这种情况与母亲和产后不良事件的风险增加有关。在20世纪70年代中期,每1000名35 - 39岁的孕妇中有1.7人怀孕,到2012年,这一数字上升到每1000名孕妇中有11人,增长了6倍。据估计,全球35岁以上孕妇的患病率为12.3%。描述了40岁或40岁以上无产者的产妇和围产期特征和结果,并将其与40岁以下无产者的特征进行了比较。这项研究时采取了一个病人4095 nulíparas女性大致符合列入的标准,然而,被发现在它限制了人口被关在一个高度复杂的三级医院,大多数教育程度和社会经济水平高的中产阶级。总之,老年妇女是高危人群,对她们的管理和监测需要采取不同的方法来改善产妇和产后的结果。
{"title":"[Advanced maternal age as a risk factor for adverse perinatal outcomes]","authors":"Anyhely Yhoan Escudero Quispe, José Luis Vivanco Osorio","doi":"10.31053/1853.0605.v82.n1.45349","DOIUrl":"10.31053/1853.0605.v82.n1.45349","url":null,"abstract":"<p><p>This study finds a gradual increase in women's age at first pregnancy, a situation that has been associated with an increased risk of adverse maternal and postpartum events. While in the mid-1970s there were 1.7 per thousand pregnant nulliparous women between 35 and 39 years old, in 2012 this figure increased to 11 per thousand pregnant women, a six-fold increase. The global prevalence of pregnant women over 35 years of age is estimated at 12.3%. Maternal and perinatal characteristics and outcomes of nulliparous women aged 40 years and older are described and compared with characteristics of nulliparous women younger than 40 years. During the time of said study, approximately 4095 nulliparous female patients who met the inclusion criteria were treated; however, a limitation was found because it was a closed population treated in a highly complex tertiary hospital, the majority with high level of schooling and middle class socioeconomic level. In conclusion, older women constitute a high-risk population whose management and follow-up would require a different approach aimed at improving maternal and postpartum outcomes.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"223-230"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057714/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[ Accumulation of hyaluronic acid in rhinoseptoplasty: intraoperative finding] 鼻整形术中透明质酸的积累。
Q3 Medicine Pub Date : 2025-03-31 DOI: 10.31053/1853.0605.v82.n1.45169
Sebastián Abad-Cuenca, Xavier Eduardo Abad-González

Current beauty standards have influenced individuals to seek an aesthetically "ideal" nose, leading them to pursue non-surgical strategies like rhinomodeling using hyaluronic acid or surgical approaches such as rhinoplasty. The use of hyaluronic acid in the nose can complicate its manipulation in the event of subsequent surgical intervention and carries various risks if performed by unqualified personnel.

目前的美容标准已经影响到人们在寻找美学上“理想”的鼻子时,诉诸于使用透明质酸的非手术整形策略,或像鼻整形这样的手术策略。在鼻子水平使用透明质酸可能会使随后的手术操作复杂化,如果由未经培训的人员使用,还会带来一些风险。
{"title":"[ Accumulation of hyaluronic acid in rhinoseptoplasty: intraoperative finding]","authors":"Sebastián Abad-Cuenca, Xavier Eduardo Abad-González","doi":"10.31053/1853.0605.v82.n1.45169","DOIUrl":"10.31053/1853.0605.v82.n1.45169","url":null,"abstract":"<p><p>Current beauty standards have influenced individuals to seek an aesthetically \"ideal\" nose, leading them to pursue non-surgical strategies like rhinomodeling using hyaluronic acid or surgical approaches such as rhinoplasty. The use of hyaluronic acid in the nose can complicate its manipulation in the event of subsequent surgical intervention and carries various risks if performed by unqualified personnel.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"215-222"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057700/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Validation of a new impedance cardiography device for noninvasive hemodynamic measurement in outpatient hypertensive patients] [一种新型阻抗心电图仪在门诊高血压患者无创血流动力学测量中的验证]
Q3 Medicine Pub Date : 2025-03-31 DOI: 10.31053/1853.0605.v82.n1.45253
Marcelo A Rada, Paula Edit Cuffaro, María Celeste Szydlowicz, Verónica Andrea Peuchot, Margarita Susana Morales, Jorge Javier Janson, Ruben Micali, José Alfie, Carlos Rodolfo Galarza

Objective: To compare the new cardiograph ZLogic for non-invasive measurements of Stroke volume (SV) and Cardiac output (CO) against the Minnesota cardiograph.

Methods: 86 subjects from both genders, 18-80 years old, hypertensive and healthy volunteers were included. Three hemodynamic measurements performed with each device, in an alternate fashion, using the Bland-Altman method to determine the level of agreement. Percentage error was calculated for interchangeability of both methods.

Results: Mean SV was 86.71±27.35 mL and mean CO 5.42±1.74 L/min. There was a strong correlation between measures of SV and CO obtained with both devices (r=0.99, p<0.001). Mean difference (MD) for SV was 0.65±3.08 mL (CI95%: -0.01-1.31) and 95% limits of agreement −5.39 to +6.69 mL. MD for CO was 0.05±0.17 L/min (CI95%: 0.01-0.09) and the 95% limits of agreement −0.28 to +0.38 L/min.

Conclusion: ZLogic and Minnesota cardiographs provided equivalent SV and CO values in ambulatory hypertensive patients.

目的:比较新型心电仪ZLogic与明尼苏达州心电仪在无创测量脑卒中容积(SV)和心输出量(CO)方面的差异。方法:选取年龄在18 ~ 80岁、高血压和健康志愿者共86例。使用Bland-Altman方法对每个设备进行三次血流动力学测量,以替代方式确定一致性水平。计算了两种方法互换性的百分比误差。结果:平均SV为86.71±27.35 mL,平均CO为5.42±1.74 L/min。两种仪器测量的SV和CO之间存在很强的相关性(r=0.99, p)。结论:ZLogic和Minnesota心动图为门诊高血压患者提供了相同的SV和CO值。
{"title":"[Validation of a new impedance cardiography device for noninvasive hemodynamic measurement in outpatient hypertensive patients]","authors":"Marcelo A Rada, Paula Edit Cuffaro, María Celeste Szydlowicz, Verónica Andrea Peuchot, Margarita Susana Morales, Jorge Javier Janson, Ruben Micali, José Alfie, Carlos Rodolfo Galarza","doi":"10.31053/1853.0605.v82.n1.45253","DOIUrl":"10.31053/1853.0605.v82.n1.45253","url":null,"abstract":"<p><strong>Objective: </strong>To compare the new cardiograph ZLogic for non-invasive measurements of Stroke volume (SV) and Cardiac output (CO) against the Minnesota cardiograph.</p><p><strong>Methods: </strong>86 subjects from both genders, 18-80 years old, hypertensive and healthy volunteers were included. Three hemodynamic measurements performed with each device, in an alternate fashion, using the Bland-Altman method to determine the level of agreement. Percentage error was calculated for interchangeability of both methods.</p><p><strong>Results: </strong>Mean SV was 86.71±27.35 mL and mean CO 5.42±1.74 L/min. There was a strong correlation between measures of SV and CO obtained with both devices (r=0.99, p<0.001). Mean difference (MD) for SV was 0.65±3.08 mL (CI95%: -0.01-1.31) and 95% limits of agreement −5.39 to +6.69 mL. MD for CO was 0.05±0.17 L/min (CI95%: 0.01-0.09) and the 95% limits of agreement −0.28 to +0.38 L/min.</p><p><strong>Conclusion: </strong>ZLogic and Minnesota cardiographs provided equivalent SV and CO values in ambulatory hypertensive patients.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"95-109"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057702/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Outcomes of a Transdisciplinary Rehabilitation Program for Patients with Consciousness Disorders (2006-2022, Argentina)] [一项针对意识障碍患者的跨学科康复项目的结果(2006-2022,阿根廷)]
Q3 Medicine Pub Date : 2025-03-31 DOI: 10.31053/1853.0605.v82.n1.42871
Maria Elisa Rivas, Melania Ron, Fernando Martín Salierno, María Soledad Broggi, Lucas Bonamico

Introduction: After suffering brain damage with altered consciousness, clinically stable patients are referred to rehabilitation programs. The objective of this study is to describe the results of a transdisciplinary multisensory stimulation program in adults with altered consciousness admitted to a rehabilitation center in Argentina between 2006 and 2022.

Methodology: A retrospective case series study was conducted that included 178 patients who completed the multisensory stimulation program. Consciousness was assessed with the Coma Recovery Scale – Revised (CRS-R), functional outcome with the Functional Independence Measure (FIM), and disability with the Disability Rating Scale (DRS).

Results: The majority of patients (68%) were men with a diagnosis of unresponsive wakefulness syndrome (RSVS). The median time of injury to admission was 77 days, and the average length of stay was 127 days. The median CRS-R at admission was 6 and 10 at discharge (p = 0.01). The highest percentage (61.8%) of emergence was in traumatic injuries. Patients who emerged showed a significant functional improvement, with a median FIM = 44 and DRS = 11. The stay was significantly shorter in those who emerged (70 vs. 163 days; p = 0.001).

Conclusion: These results highlight the benefit of a transdisciplinary multisensory stimulation program to improve diagnostic evaluation and promote recovery of consciousness in patients with severe brain injury.

简介:在遭受脑损伤并意识改变后,临床稳定的患者被转介到康复计划。本研究的目的是描述2006年至2022年间阿根廷一家康复中心收治的意识改变成人的跨学科多感官刺激计划的结果。方法:对178例完成多感觉刺激计划的患者进行回顾性病例系列研究。用昏迷恢复量表(CRS-R)评估意识,用功能独立性量表(FIM)评估功能结局,用残疾评定量表(DRS)评估残疾。结果:大多数患者(68%)为诊断为无反应性觉醒综合征(RSVS)的男性。受伤至住院的中位时间为77天,平均住院时间为127天。入院时中位CRS-R为6,出院时为10 (p = 0.01)。急诊比例最高的是外伤性损伤(61.8%)。出现的患者表现出显著的功能改善,中位FIM = 44, DRS = 11。出现的患者停留时间明显缩短(70天vs 163天;P = 0.001)。结论:这些结果强调了跨学科多感觉刺激计划在改善重型脑损伤患者的诊断评估和促进意识恢复方面的益处。
{"title":"[Outcomes of a Transdisciplinary Rehabilitation Program for Patients with Consciousness Disorders (2006-2022, Argentina)]","authors":"Maria Elisa Rivas, Melania Ron, Fernando Martín Salierno, María Soledad Broggi, Lucas Bonamico","doi":"10.31053/1853.0605.v82.n1.42871","DOIUrl":"10.31053/1853.0605.v82.n1.42871","url":null,"abstract":"<p><strong>Introduction: </strong>After suffering brain damage with altered consciousness, clinically stable patients are referred to rehabilitation programs. The objective of this study is to describe the results of a transdisciplinary multisensory stimulation program in adults with altered consciousness admitted to a rehabilitation center in Argentina between 2006 and 2022.</p><p><strong>Methodology: </strong>A retrospective case series study was conducted that included 178 patients who completed the multisensory stimulation program. Consciousness was assessed with the Coma Recovery Scale – Revised (CRS-R), functional outcome with the Functional Independence Measure (FIM), and disability with the Disability Rating Scale (DRS).</p><p><strong>Results: </strong>The majority of patients (68%) were men with a diagnosis of unresponsive wakefulness syndrome (RSVS). The median time of injury to admission was 77 days, and the average length of stay was 127 days. The median CRS-R at admission was 6 and 10 at discharge (p = 0.01). The highest percentage (61.8%) of emergence was in traumatic injuries. Patients who emerged showed a significant functional improvement, with a median FIM = 44 and DRS = 11. The stay was significantly shorter in those who emerged (70 vs. 163 days; p = 0.001).</p><p><strong>Conclusion: </strong>These results highlight the benefit of a transdisciplinary multisensory stimulation program to improve diagnostic evaluation and promote recovery of consciousness in patients with severe brain injury.</p>","PeriodicalId":38814,"journal":{"name":"Revista de la Facultad de Ciencias Medicas de Cordoba","volume":"82 1","pages":"6-21"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057715/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista de la Facultad de Ciencias Medicas de Cordoba
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1